Published in Exp Clin Psychopharmacol on November 01, 1997
Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict Biol (2008) 1.32
Daily life hour by hour, with and without cocaine: an ecological momentary assessment study. Psychopharmacology (Berl) (2010) 1.21
Sleep quality deteriorates over a binge--abstinence cycle in chronic smoked cocaine users. Psychopharmacology (Berl) (2005) 1.17
The effects of aerobic exercise on cocaine self-administration in male and female rats. Psychopharmacology (Berl) (2011) 1.08
A paradigm to investigate the self-regulation of cocaine administration in humans. Psychopharmacology (Berl) (2005) 0.99
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend (2010) 0.97
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics. Exp Clin Psychopharmacol (2009) 0.94
Evidence for habitual and goal-directed behavior following devaluation of cocaine: a multifaceted interpretation of relapse. PLoS One (2009) 0.93
Psychostimulant addiction treatment. Neuropharmacology (2014) 0.91
The effects of social contact on cocaine intake under extended-access conditions in male rats. Exp Clin Psychopharmacol (2016) 0.84
Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases. Pharmacol Biochem Behav (2009) 0.79
EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES. NIDA Res Monogr (2005) 0.76
Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94
The pharmacology of cocaine related to its abuse. Pharmacol Rev (1989) 2.49
Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) (1999) 2.27
Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET. Synapse (1997) 2.15
Satiety after preloads with different amounts of fat and carbohydrate: implications for obesity. Am J Clin Nutr (1994) 1.97
Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA (1996) 1.95
Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl) (1999) 1.81
Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry (1993) 1.71
Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci (2000) 1.54
Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology (2001) 1.53
Alternative reinforcers differentially modify cocaine self-administration by humans. Behav Pharmacol (2000) 1.41
Methamphetamine self-administration by humans. Psychopharmacology (Berl) (2001) 1.40
Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) (2001) 1.40
Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science (1978) 1.37
Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology (Berl) (2001) 1.36
Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther (1991) 1.36
Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite (1988) 1.29
Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol (1997) 1.29
Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine. J Anal Toxicol (1993) 1.28
Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology (Berl) (1999) 1.24
Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry (1976) 1.22
Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther (1985) 1.22
Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol (1998) 1.21
Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend (1976) 1.15
Time course of effects of preloads high in fat or carbohydrate on food intake and hunger ratings in humans. Am J Physiol (1991) 1.14
Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology (Berl) (1999) 1.14
Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology (Berl) (1998) 1.12
Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend (1991) 1.10
Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J Anal Toxicol (1993) 1.09
Factors influencing marijuana self-administration by humans. Behav Pharmacol (1997) 1.08
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology (Berl) (2001) 1.08
Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav (1987) 1.08
'Hangover' effects the morning after marijuana smoking. Drug Alcohol Depend (1985) 1.06
Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. J Chromatogr B Biomed Sci Appl (1999) 1.06
Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl) (2001) 1.05
Effects of smoked marijuana on social interaction in small groups. Drug Alcohol Depend (1987) 1.04
Ethanol and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav (1988) 1.02
Limited sex differences in response to "binge" smoked cocaine use in humans. Neuropsychopharmacology (1999) 1.02
Cocaine self-administration in humans. Fed Proc (1982) 1.00
Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am J Psychiatry (1993) 1.00
Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend (1993) 0.99
Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther (1992) 0.98
Iatrogenous cocaine psychosis. N Engl J Med (1982) 0.98
Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend (1990) 0.98
Kinetics of cocaine distribution, elimination, and chronotropic effects. Clin Pharmacol Ther (1985) 0.97
Behavioral analysis of marijuana effects on food intake in humans. Pharmacol Biochem Behav (1986) 0.95
Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans. Psychopharmacology (Berl) (2001) 0.93
The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther (1992) 0.93
Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend (1988) 0.93
Internal stimulus control and subjective effects of drugs. NIDA Res Monogr (1981) 0.92
Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology (Berl) (1996) 0.92
Binge cocaine self-administration by humans: smoked cocaine. Behav Pharmacol (1997) 0.91
Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans. Drug Alcohol Depend (2001) 0.90
Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther (1996) 0.90
Effects of caloric manipulations on food intake in baboons. Appetite (1990) 0.89
The behavioral pharmacology of cocaine in humans. NIDA Res Monogr (1984) 0.89
The effects of combinations of intranasal cocaine, smoked marijuana, and task performance on heart rate and blood pressure. Pharmacol Biochem Behav (1990) 0.89
Methods for the assessment of abuse liability of psychomotor stimulants and anorectic agents in humans. Br J Addict (1991) 0.88
Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berl) (1997) 0.88
Effects of d-amphetamine on task performance and social behavior of humans in a residential laboratory. Exp Clin Psychopharmacol (1997) 0.87
Are choice and self-administration of marijuana related to delta 9-THC content? Exp Clin Psychopharmacol (1997) 0.86
Motivational effects of smoked marijuana: behavioral contingencies and low-probability activities. J Exp Anal Behav (1990) 0.86
A comparison of the subjective and cardiovascular effects of cocaine and procaine in humans. Pharmacol Biochem Behav (1983) 0.86
Effect of fenfluramine on food intake, mood, and performance of humans living in a residential laboratory. Physiol Behav (1996) 0.86
Effects of "binge" use of intravenous cocaine in methadone-maintained individuals. Addiction (1998) 0.86
Cardiovascular effects of cocaine. N Engl J Med (1976) 0.85
Caloric compensation for lunches varying in fat and carbohydrate content by humans in a residential laboratory. Am J Clin Nutr (1990) 0.85
Multidimensional behavioral effects of marijuana. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.85
Tolerance development to chronic methamphetamine intoxication in the rhesus monkey. Pharmacol Biochem Behav (1975) 0.85
The effects of a monetary alternative on marijuana self-administration. Behav Pharmacol (1997) 0.85
The effects of repeated amphetamine exposure on multiple measures of human behavior. Pharmacol Biochem Behav (1991) 0.84
The effects of varying procurement costs on food intake in baboons. Physiol Behav (1988) 0.84
Cocaine effects in sleep-deprived humans. Psychopharmacology (Berl) (1980) 0.84
Effects of smoked marijuana on human social behavior in small groups. Pharmacol Biochem Behav (1988) 0.84
Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharmacology (1998) 0.84
Residual effects of repeated cocaine smoking in humans. Drug Alcohol Depend (1997) 0.84
The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav Pharmacol (1998) 0.84
Cocaine self-administration research: treatment implications. NIDA Res Monogr (1994) 0.83
Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J Pharmacol Exp Ther (1995) 0.83
Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans. Behav Pharmacol (1998) 0.83
Fluoxetine-maintained obese humans: effect on food intake and body weight. Physiol Behav (1999) 0.82
Increased sensitivity to alprazolam in females with a paternal history of alcoholism. Psychopharmacology (Berl) (2000) 0.82
The regularity of smoked marijuana self-administration. Pharmacol Biochem Behav (1989) 0.82
Positron emission tomography studies of dopamine-enhancing drugs. J Clin Pharmacol (1999) 0.82
Cardiovascular effects of cocaine in humans: laboratory studies. Drug Alcohol Depend (1995) 0.81
The effects of d-amphetamine on food intake of humans living in a residential laboratory. Appetite (1990) 0.81
Food intake in baboons: effects of d-amphetamine and fenfluramine. Pharmacol Biochem Behav (1988) 0.80
Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking. J Exp Anal Behav (1994) 0.80
Smoked marijuana effects on tobacco cigarette smoking behavior. J Pharmacol Exp Ther (1990) 0.80
Single-dose study of nabilone in anxious volunteers. J Clin Pharmacol (1982) 0.80
Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans. Behav Pharmacol (1999) 0.80
The effects of cocaine on food intake of baboons before, during, and after a period of repeated desipramine. Pharmacol Biochem Behav (1990) 0.80
A protocol to switch high-dose, methadone-maintained subjects to buprenorphine. Am J Addict (1997) 0.80
A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans. Pharmacol Biochem Behav (1983) 0.80
Cognitive dysfunction and imipramine in outpatient depressive. Arch Gen Psychiatry (1981) 0.80
Pattern of cocaine use in methadone-maintained individuals applying for research studies. J Addict Dis (1996) 0.79
A single dose study of nabilone, a synthetic cannabinoid. Psychopharmacology (Berl) (1980) 0.79
Amphetamine toxicity: behavioral and neuropathological indexes. Fed Proc (1975) 0.79
Effects of delta 9-tetrahydrocannabinol and social context on marijuana self-administration by humans. Pharmacol Biochem Behav (1994) 0.79
Behavioral effects of alprazolam in humans. Behav Pharmacol (1997) 0.79